PRODUCTS
SERVICES
The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies engaged in Pharma and Healthcare.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
2.35
3 yrs 1 m
1%
217.92 Crs
1% on or before 12M, Nil after 12M
Large Growth
8.51
SIP 500 & Lumpsum 5000
NA
Rohan Korde,Dhimant Shah
Investors understand that their principal will be at very high risk